Article Information
History
- September 30, 2021.
Article Versions
- Version 1 (March 22, 2021 - 08:25).
- Version 2 (March 24, 2021 - 10:19).
- Version 3 (May 13, 2021 - 09:18).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Achal Patel, MPH1,
- Montserrat García-Closas, MD, DrPH2,3,
- Andrew F. Olshan, PhD1,4,
- Charles M. Perou, PhD4,5,6,
- Melissa A. Troester, PhD1,6,
- Michael I. Love, PhD5,7 and
- Arjun Bhattacharya, PhD8,9,*
- 1Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
- 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
- 3Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
- 4Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel Hill, USA
- 5Department of Genetics, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
- 6Department of Pathology and Laboratory Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
- 7Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
- 8Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA
- 9Institute for Quantitative and Computational Biosciences, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA
- ↵*Correspondence can be directed to AB (abtbhatt{at}ucla.edu)
Posted September 30, 2021.
Gene-level germline contributions to clinical risk of recurrence scores in Black and White breast cancer patients
